Ultima-Selank 10mg

MANUFACTURER Ultima Pharmaceuticals - USA
WAREHOUSE USA Warehouse 5
SUBSTANCE Selank

Our products are shipped without brand labels to ensure your privacy and security.

As the field of biotechnology rapidly evolves, innovative biologically active substances, known as "cognitive enhancers" or "nootropics," are being explored. One standout compound in this category is Selank, previously known as ?TP-7.? This synthetic peptide is a meticulously engineered small protein.

Celebrated for its anti-anxiety properties, Selank is also touted for its ability to enhance learning and energize users, all purportedly without any side effects or addiction risks. This compact molecule is notably smaller than most natural proteins and was developed through a collaborative effort between the Institute of Molecular Genetics and the V.V. Zakusov Research Institute of Pharmacology, both esteemed institutions within the Russian Academy of Sciences, alongside its counterpart, Semax.

Selank was crafted by combining sequences from a natural peptide called tuftsin, which is a component of the natural antibody IgG, with another sequence that boosts its molecular stability. Both tuftsin and Selank have demonstrated the potential to reduce anxiety and elevate serotonin levels in animal studies, with Selank showing slightly superior efficacy.

In Russia, Selank is approved for the treatment of generalized anxiety disorder (GAD) and is recognized for its nootropic effects. While it has not gained FDA approval for any medical conditions in the U.S., Selank remains available in various countries, often marketed as a ?nutritional supplement.?

The exact mechanisms by which Selank operates are still being studied. It is believed to stabilize enkephalins in the bloodstream, which are natural peptides that help mitigate stress responses. However, mouse studies have not confirmed this enkephalin stabilization or demonstrated significant anti-anxiety effects.

Research indicates that Selank may interact with GABA receptors, similar to many sedative compounds. Mice treated with Selank showed heightened activity in GABA-dependent inhibitory neurons, correlating with reduced overall brain activity. Furthermore, some studies suggest an increase in BDNF, a crucial neurotrophic factor associated with learning and memory, possibly explaining some of Selank's cognitive benefits.

Evidence also hints that Selank may influence neurotransmitter levels such as norepinephrine, dopamine, and serotonin in mice. These neurotransmitters are crucial for motivation, focus, and pleasure. However, findings are mixed; one study showed increased norepinephrine but decreased dopamine and serotonin, while another indicated a rise in both norepinephrine and dopamine without affecting serotonin levels. Consequently, the precise effects and mechanisms of Selank remain somewhat unclear.

In preliminary clinical trials with 62 participants, Selank was associated with a reduction in anxiety symptoms, particularly in individuals with existing anxiety disorders. Another trial involving 60 patients with anxiety and phobias reported similar benefits, with effects lasting up to one week post-treatment. Additionally, among 70 anxiety patients, Selank was found to enhance the effects of phenazepam (a restricted anti-anxiety medication in the U.S.) while minimizing side effects like drowsiness and memory loss. Animal studies have also indicated that Selank can alleviate anxiety in mice, with the most anxious subjects showing significant behavioral improvements. While these findings are promising, further research is necessary to confirm Selank's efficacy and safety in humans. If you are considering Selank for anxiety, consulting a healthcare provider is essential, and it should not replace prescribed treatments without professional advice.

A study indicated that Selank may stabilize memory traces, potentially enhancing memory retention in rats over a 30-day period, although the measurement methods remain unclear. Another study suggested Selank might help preserve memory in monkeys, yet adequate human studies are lacking to ascertain its effects on healthy individuals, necessitating caution until further research is conducted.

One study demonstrated that Selank administered to rats with toxin-induced brain damage could restore normal brain activity levels.

Selank has shown promise in reducing symptoms of depression in mice (as indicated by immobility in forced swimming tests), proving to be more effective at lower doses than at higher ones.

A preliminary animal study suggested that Selank injections boosted antioxidant levels in the livers of stressed mice.

In a study involving sedated cats, Selank reduced blood pressure by approximately 30% for up to 3 minutes and increased cerebral blood flow by around 24% for up to 10 minutes. However, these preliminary findings raise questions about their clinical significance, particularly given their limited applicability to healthy humans.

Since anxiety is a common symptom of alcohol withdrawal, a study found that rats treated with Selank after a simulated high alcohol intake exhibited reduced anxiety following a 48-hour withdrawal period.

In an animal study, rats on a high-fat diet experienced 35% less weight gain while treated with Selank. Additionally, total cholesterol levels dropped by over 58%, and blood glucose levels decreased by 23.5%.

In an animal model, mice with breast cancer treated daily with Selank showed slower tumor growth and longer survival rates compared to untreated mice. However, these initial findings do not endorse Selank as a viable cancer therapy; extensive further research is necessary to explore any medicinal use for cancer treatment, and it should never replace conventional cancer treatments.

Post-treatment with Selank, increases in several inflammatory response genes were noted in the spleens of mice, suggesting potential protective benefits against inflammation.

Research has indicated that Selank can reduce the area of stomach ulcers in animal studies, potentially due to increased lymph flow to the stomach, an essential immune system component. More comprehensive human research is necessary to validate this effect.

Selank has been reported to elevate IL-6 levels in the blood of depressed patients, with IL-6 being an inflammatory protein that aids in fighting infections. Moreover, one cell-based study indicated that Selank may stimulate the release of interferons, known for their anti-viral properties. Although some evidence suggests Selank could offer protection against certain viral infections, a study in mice infected with a virus showed no anti-viral benefits from Selank treatment, casting doubt on this potential application.